| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.3 | 0.09 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |